News Releases

May 14, 2021
Japan Display Inc.

JDI Announces Development of High-brightness & Ultra-high-contrast ratio
LCD for Medical Monitors

- 21.3inch 5MPixel Monochrome LCD -

Japan Display Inc. (JDI) today announced the development of a 21.3-inch 5mega-pixel monochrome LCD (2048 × 2560ppi) with High-brightness and High-contrast ratio TFT display made by Dual-cell ^(*1) technology.

(Photos are for illustrative purposes.)

In the medical field, displays are required to have accurate image quality with, high-brightness, and high-contrast for the best image diagnosis. JDI has developed a 21.3-inch high resolution (5mega-pixel) monochrome TFT display incorporating our new Dual-cell technology to meet the needs for higher performance displays required by the medical market demands.
JDI devised the LCD structure to control dimming of the panel to solve double images and missing images due to viewing angles and a halo effects caused by the combination of a reducing parallax and an optimization of the dimming area. The result greatly improves the display quality that can then be applied as a medical diagnostic solution.

To achieve such high-definition image quality and high brightness, JDI utilizes LTPS technology for wide viewing angles and high contrast by means of IPS liquid crystal.

Sample shipment of this product will start in May.

【General Specifications】

	Specifications (Target)
Display size	21.3 inch
Resolution	2048 × 2560
Pixel density	154ppi
Contrast ratio	≧ 500,000 : 1
Brightness	1,000 cd / m² (Max)
Grayscale tones	1,024 (Real 10 bit)
Power consumption	≦ 50Ｗ
Size	(H) 337.92mm × (V)422.4mm
Bezel width	5.54mm

^※Calibration brightness during actual use 600cd / m² (According to our research)

This product will be exhibited at our virtual booth of "SID DISPLAY WEEK 2021".

^(*1)Dual-cell :

2-layer LCD structure that improves the contrast of the display by stacking the image display panel on top of the dimming panel.

The information contained in this press release is accurate as of the date of issuance and is subject to change without notice. Information in this press release, other than statements of historical fact, constitutes forward-looking statements, which are based on available information, operating plans and projections about future events and trends. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in such forward-looking statements.

Links marked with this symbol will open a new window